These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11514726)

  • 1. Antigenic variants with amino acid deletions clarify a neutralizing epitope specific for influenza B virus Victoria group strains.
    Nakagawa N; Kubota R; Nakagawa T; Okuno Y
    J Gen Virol; 2001 Sep; 82(Pt 9):2169-2172. PubMed ID: 11514726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralizing epitopes specific for influenza B virus Yamagata group strains are in the 'loop'.
    Nakagawa N; Kubota R; Nakagawa T; Okuno Y
    J Gen Virol; 2003 Apr; 84(Pt 4):769-773. PubMed ID: 12655076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of the neutralizing epitope common to influenza B virus victoria group isolates in Japan.
    Nakagawa N; Suzuoki J; Kubota R; Kobatake S; Okuno Y
    J Clin Microbiol; 2006 Apr; 44(4):1564-6. PubMed ID: 16597895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of new epidemic strains of influenza B virus by using neutralizing monoclonal antibodies.
    Nakagawa N; Kubota R; Morikawa S; Nakagawa T; Baba K; Okuno Y
    J Med Virol; 2001 Dec; 65(4):745-50. PubMed ID: 11745940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monoclonal antibodies to hemagglutinin of influenza b viruses victoria evolutionary lineage.].
    Sorokin EV; Tsareva TR; Zheltukhina AI
    Vopr Virusol; 2018; 63(6):275-280. PubMed ID: 30641023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation of the conserved neutralizing epitope in influenza B virus victoria group isolates in Japan.
    Nakagawa N; Kubota R; Okuno Y
    J Clin Microbiol; 2005 Aug; 43(8):4212-4. PubMed ID: 16081981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of influenza B virus strains in one epidemic season differentiated by monoclonal antibodies and nucleotide sequences.
    Nakagawa N; Kubota R; Maeda A; Nakagawa T; Okuno Y
    J Clin Microbiol; 2000 Sep; 38(9):3467-9. PubMed ID: 10970406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epitope analysis of the hemagglutinin molecule of the Victoria lineage influenza B viruses].
    Sorokin EV; Tsareva TR; Sominina AA; Pisareva MM; Komissarov AV; Kosheleva AA; Grudinin MP
    Vopr Virusol; 2014; 59(6):27-31. PubMed ID: 25929033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An analysis of the properties of monoclonal antibodies directed to epitopes on influenza virus hemagglutinin.
    Brown LE; Murray JM; White DO; Jackson DC
    Arch Virol; 1990; 114(1-2):1-26. PubMed ID: 1699509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid detection and identification of two lineages of influenza B strains with monoclonal antibodies.
    Nakagawa N; Maeda A; Kase T; Kubota R; Okuno Y
    J Virol Methods; 1999 Apr; 79(1):113-20. PubMed ID: 10328540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralization escape mutants of type A influenza virus are readily selected by antisera from mice immunized with whole virus: a possible mechanism for antigenic drift.
    Lambkin R; McLain L; Jones SE; Aldridge SL; Dimmock NJ
    J Gen Virol; 1994 Dec; 75 ( Pt 12)():3493-502. PubMed ID: 7527838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolutionary dynamic of antigenic residues on influenza B hemagglutinin.
    Suptawiwat O; Ninpan K; Boonarkart C; Ruangrung K; Auewarakul P
    Virology; 2017 Feb; 502():84-96. PubMed ID: 28024225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies.
    Kaverin NV; Rudneva IA; Govorkova EA; Timofeeva TA; Shilov AA; Kochergin-Nikitsky KS; Krylov PS; Webster RG
    J Virol; 2007 Dec; 81(23):12911-7. PubMed ID: 17881439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of cross-clade monoclonal antibodies against H5N1 highly pathogenic avian influenza virus and their application to the antigenic analysis of diverse H5 subtype viruses.
    Gronsang D; Bui AN; Trinh DQ; Bui VN; Nguyen KV; Can MX; Omatsu T; Mizutani T; Nagai M; Katayama Y; Thampaisarn R; Ogawa H; Imai K
    Arch Virol; 2017 Aug; 162(8):2257-2269. PubMed ID: 28405766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel humanized antibody neutralizes H5N1 influenza virus via two different mechanisms.
    Tan Y; Ng Q; Jia Q; Kwang J; He F
    J Virol; 2015 Apr; 89(7):3712-22. PubMed ID: 25609802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reverse engineering the antigenic architecture of the haemagglutinin from influenza H5N1 clade 1 and 2.2 viruses with fine epitope mapping using monoclonal antibodies.
    Rockman S; Camuglia S; Vandenberg K; Ong C; Baker MA; Nation RL; Li J; Velkov T
    Mol Immunol; 2013 Apr; 53(4):435-42. PubMed ID: 23127859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influenza viruses which preconditioned the epidemic rise in Russia in 2002-2003. A resumed circulation of influenza viruses similar to V/Victoria/2/87].
    Ivanova VT; Burtseva EI; Slepushkin AN; Oskerko TA; Zagorskaia IuV; Shevchenko ES; Mashkova SA; Feodoritova EL
    Vopr Virusol; 2004; 49(3):12-7. PubMed ID: 15188649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly conserved sequences for human neutralization epitope on hemagglutinin of influenza A viruses H3N2, H1N1 and H5N1: Implication for human monoclonal antibody recognition.
    Yamashita A; Kawashita N; Kubota-Koketsu R; Inoue Y; Watanabe Y; Ibrahim MS; Ideno S; Yunoki M; Okuno Y; Takagi T; Yasunaga T; Ikuta K
    Biochem Biophys Res Commun; 2010 Mar; 393(4):614-8. PubMed ID: 20152806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Monoclonal antibodies with high virus-neutralizing activity against pandemic influenza virus A/llV-Moscow/01/2009 (H1N1)swl].
    Klimova RR; Masalova OV; Burtseva EI; Chichev EV; Lesnova EI; Oskerko TA; Mukasheva EA; Rudneva IA; Lvov DK; Kushch AA
    Vopr Virusol; 2011; 56(3):15-20. PubMed ID: 21786621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic and genetic characterization of the haemagglutinins of recent cocirculating strains of influenza B virus.
    Rota PA; Hemphill ML; Whistler T; Regnery HL; Kendal AP
    J Gen Virol; 1992 Oct; 73 ( Pt 10)():2737-42. PubMed ID: 1402807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.